Evidence map›Paper›PMID 20590582›Full record

ArticleBritish journal of pharmacology2010

Compromised vascular endothelial cell SK(Ca) activity: a fundamental aspect of hypertension?

Christopher J Garland

Open access · bronzeAbstract readComment
In one paragraph

Article in British journal of pharmacology, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
1.9field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 21 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Berberine protects vascular endothelial cells in hypertensive rats.International journal of clinical and experimental medicine · 2015
    Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. The vascular endothelium: still amazing us 30 years on.British journal of pharmacology · 2011
    Article
  11. Article
  12. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

1 author at 1 institution in 1 country.

Christopher J GarlandDepartment of Pharmacology, University of Oxford, Oxford, UK. christopher.garland@pharm.ox.ac.uk
University of Oxford · GB

Funding

British Heart FoundationWellcome Trust
6 · The paper itself

Abstract

Smooth muscle hyperpolarization originating in the endothelium and commonly referred to as the EDHF (endothelium-derived hyperpolarizing factor) response provides a very significant drive to vasodilatation particularly in small resistance arteries. Together with other endothelium-dependent dilator pathways 'EDHF' hyperpolarization is compromised by cardiovascular disease, including hypertension. However, although attenuated vascular hyperpolarization has been described in animal models of hypertension, the underlying mechanisms are not fully understood. In the current issue of the British Journal of Pharmacology, Weston et al. combine classic pharmacological approaches with electrophysiological and molecular techniques to suggest that attenuated endothelium-dependent hyperpolarization (and as a consequence vasodilatation) reflects major disruption of pathways associated with the activation of endothelial small conductance Ca(2+)-activated K-channels (SK(Ca)) in mesenteric arteries from spontaneously hypertensive rats. In addition to reductions in SK(Ca) and K(IR) proteins, changes in caveolin-1 isomers were also detected, possibly indicating channel realignment within plasmalemmal structures.

Indexed as

AnimalsAntihypertensive AgentsBiological FactorsDown-RegulationHypertensionMembrane MicrodomainsMembrane PotentialsMembrane Transport ModulatorsMesenteric ArteriesPotassium Channels, Inwardly RectifyingRatsRats, Inbred SHRSignal TransductionSmall-Conductance Calcium-Activated Potassium ChannelsVasodilationAntihypertensive AgentsBiological Factorsendothelium-dependent hyperpolarization factorMembrane Transport ModulatorsPotassium Channels, Inwardly RectifyingSmall-Conductance Calcium-Activated Potassium Channels

Identifiers

PMID20590582
PMCPMC2935990
OpenAlexW1607977021

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.